IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bellevue Group AG

Q2 2024 Holdings

Filed 2024-08-14 | 204 holdings | $6.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Edwards Lifesciences Corp(EW)COM28176E108$116.4M1,260,4611.9%
Incyte Corp(INCY)COM45337C102$130.5M2,153,5042.1%
Dexcom Inc(DXCM)COM252131107$143.8M1,268,6872.3%
Abbott Labs(ABT)COM002824100$166.9M1,606,1532.7%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$167.3M3,879,5482.7%
Intra-Cellular Therapies Inc(ITCIEUR)COM46116X101$169.3M2,471,2852.8%
Moderna Inc(MRNA)COM60770K107$185.7M1,563,7353.0%
Stryker Corporation(SYK)COM863667101$185.8M545,9343.0%
Revolution Medicines Inc(RVMD)COM76155X100$195.2M5,029,1003.2%
Boston Scientific Corp(BSX)COM101137107$197.9M2,569,5883.2%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$223.5M919,8343.6%
Intuitive Surgical Inc(ISRG)COM NEW46120E602$240.2M539,9043.9%
Neurocrine Biosciences Inc(NBIX)COM64125C109$261.4M1,898,6404.2%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$278.2M593,4614.5%
Argenx SE(ARGX)SPONSORED ADR04016X101$297.5M691,8744.8%
Ionis Pharmaceuticals Inc(IONS)COM462222100$393.7M8,260,4346.4%
PreviousPage 4 of 4